| ²é¿´: 1975 | »Ø¸´: 22 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÕâÑùµÄÉó¸åÒâ¼û£¬ÎÒµÄÎÄÕÂÔõô·¢ÄØ£¿
|
|||
|
È¥ÄêÉó¸åÒâ¼û»ØÀ´ÁË£¬µ±Ê±ÎÒ¾ÍÕð¾ªÁË£¬Ò²Óеã»ÒÐÄ¡£¡£¡£¡£¡£ ½ñÄ껹ÊǵÃÊÕʰ£¬Çë´ó¼Ò°ïÎÒ¿´¿´Õâ¸öÉó¸åÒâ¼û. ÎÒÏë¼ÌÐø·¢Õâ¸öµµ´ÎµÄÓеãÎÊÌ⣬·¢µÍÒ»µãµÄÐв»£¿ÏÖÔÚÒ²²»¿ÉÄܲ¹ÊµÑéÁË£¬Ö»ÄÜÔÚд·¨ÉÏÐÞ¸ÄÁË¡£ Dear Dr., Thank you very much for submitting your above-mentioned manuscript for review to ####. After careful consideration, we have decided that your manuscript does not meet one or several of our criteria and must be rejected for publication. Specifically, I agree with the reviewer that the results you present are too preliminary to warrant publication at this stage. Unfortunately, due to the concerns described above, we cannot accept a revised version of your manuscript. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Yours sincerely, ......................................................................................... Reviewers' comments: Much is needed to be improved for this study before ready for manuscript review. First, as it is written as a methods development, at least one target gene needs to be illustrate. There are no details on methodology either. Throughout the manuscript, there is not description of this gene? There is one published paper on this, another one referred to as submitted to Plos1. What is this gene? It is up to the author to explain, not the reviewer to find out through references. Why only 2 out of 6 used were effective? There is no explanation at all. |
» ²ÂÄãϲ»¶
297Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
343Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÄϾ©´óѧ»¯Ñ§µ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧÓлú»¯Ñ§×¨Òµ£¬³õÊÔ351·Ö£¬¸´ÊÔ±»Ë¢Çóµ÷¼Á!
ÒѾÓÐ4È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶333Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
0856Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
356Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ĿǰһƪSCIÂÛÎÄÕýÔÚÉó¸åÖУ¬µ«ÏÖÔÚ·¢ÏÖÁËÎÄÕÂÖеÄһЩÎÊÌ⣬Ôõô°ì
ÒѾÓÐ41È˻ظ´
Éó¸åÒâ¼û·µ»Ø£¬ÓиöÉó¸åÈËÒªÇó²Î¿¼ËûµÄһƪÎÄÕÂ
ÒѾÓÐ10È˻ظ´
ÎÄÕµÄÉó¸åÒâ¼û£¬´ó¼Ò°ïæ¿´¿´£¡
ÒѾÓÐ6È˻ظ´
Éó¸åÖз¢ÏÖ×÷ÕßһƪÏàËÆ¶È¼«¸ßµÄÎÄÕÂÒѾÔÚÁíÒ»ÆÚ¿¯ÔÚÏߣ¬¸ÃÔõô°ì£¿
ÒѾÓÐ63È˻ظ´
·¢½ð±ÒÇóÖú ÀÏʦÈÃÎÒ°ÑÎÄÕÂÖ±½Ó·¢¸øÉó¸åÈË Óʼþ¸ÃÔõôд
ÒѾÓÐ8È˻ظ´
TalantaÎÄÕ±»¾Ü£¬µ«Çë¸÷λ°ïÎÒ¿´¿´ÕâÑùµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼
ÒѾÓÐ15È˻ظ´
ºÜÓÐȤ£ºµ±Reviewer±ä³ÉÎÄÕµĺÏ×÷Õßʱ£¬ÈçºÎ»Ø¸´ËûµÄÉó¸åÒâ¼û£¿Çë¸ßÈËÖ¸µã£¬Ð»Ð»£¡
ÒѾÓÐ35È˻ظ´
±à¼·¢´íÉó¸åÒâ¼û£¬µ«ÎÄÕÂÎÞ½øÕ¹£¬ÈçºÎ´¦Àí
ÒѾÓÐ9È˻ظ´
ÎÒ¸ø¹úÍâÆÚ¿¯ÎÄÕµÄÉó¸å½á¹ûºÍÉó¸åÒâ¼û
ÒѾÓÐ178È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Âí¶ûÎ魯âÁ£¶È+ÄÉÃ×Á£¾¶Zetaµçλ²âÊÔÔʼÊý¾ÝÓëOrigin»æÍ¼V131/2039/8821
+1/90
¸ÓÄÏʦ·¶´óѧФÐ˽ÌÊÚ¿ÎÌâ×éÕÐ2026¼¶µç×ÓÐÅϢ˶ʿ 4-6 Ãû£¬»¶Óµ÷¼Á
+1/82
Áôѧ--²©Ê¿ÕÐÉú
+1/50
»¶Ó08¿ªÍ·»ò²¿·Ö07¿ªÍ·µÄÓÐÔµÈ˱¨¿¼
+1/33
Ìì½òÀí¹¤´óѧ¹ú¼Ò½ÜÇàÍõÌúÍŶÓÕÐÆ¸
+1/29
¹þ¶û±õ¹¤Òµ´óѧ-´óÍåÇø´óѧ2026ÄêÁªºÏÅàÑø²©Ê¿Ñо¿Éú´º¼¾ÕÐÉú-±¨Ãû3ÔÂ31ºÅ½ØÖÁ
+1/14
2026Äê²ÄÁÏ/Ò±½ð/»¯¹¤Ë¶Ê¿µ÷¼Á-ÉϺ£´óѧȫ¹úÖØµãʵÑéÊÒ-¼¤¹âÒ±½ðÓë¹è»ù²ÄÁÏÖÆ±¸
+1/10
ÈýÏ¿´óѧ²Ä»¯Ñ§ÔºÄÜÔ´»·±£¾§Ì¬²ÄÁÏ¿ÎÌâ×é½ÓÊÕµ÷¼Á£¬ÕÐÊÕ»¯Ñ§Àà˶ʿ
+1/10
08¹¤Ñ§Ó¢Ò»Êý¶þ290 Èý¸ö½±Ñ§½ðÁ½¸öÊ¡Èý Ò»¸öÊ¡´´ÓÅÐã½áÏî BÇøÇóµ÷¼Á
+1/10
²©Ê¿ÕÐÉú | Çൺ¿Æ¼¼´óѧ£¨¸ß·Ö×Ó¡¢»¯Ñ§¡¢²ÄÁÏ¡¢Á¦Ñ§¡¢»úµç¹¤³Ì¡¢¼ÆËã»ú·ÂÕæ£©
+1/9
ÄþÏÄ´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÎºÒݱòÑо¿Ô±¿ÎÌâ×éÕÐÆ¸ÆôÊÂ
+1/7
¡¾²©Ê¿ÕÐÉú¡¿¹ã¶«¹¤Òµ´óѧ¹ú¼ÒÓÅÇà¿ÎÌâ×éÕÐÊÕ2026Äê»·¾³·½Ïò²©Ê¿Éú
+1/7
²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺÕÐÉú
+1/6
26Äê»·¾³²©Ê¿ÉêÇë
+1/3
Î人Àí¹¤´óѧ´¬º£ÓëÄÜÔ´¶¯Á¦¹¤³ÌѧԺÁõÅô·ÉԺʿÍŶӲ©Ê¿ºóÕÐÆ¸ÆôÊÂ
+1/3
Çóµ÷¼Á
+1/2
ÕÐÆ¸Ë¶²©Éú£º»ùÓÚ»úÆ÷ѧϰºÍÈ˹¤ÖÇÄܵĽṹ/ºÏ½ðÉè¼Æ-Î÷°²½»´ó
+1/2
Î人·ÄÖ¯´óѧ2026ÄêÕÐÊÕ˶ʿÑо¿Éú¡¾¸ßÐÔÄÜ¡¢¹¦ÄÜ·ÄÖ¯¸´ºÏ²ÄÁÏ·½Ïò¡¿
+1/2
Ó¢¹ú½£Çź÷¿³ö×â
+1/1
¹ã¶«Î¨Ò»Ê¯»¯ÔºÐ£¡ª¡ª×ÊÔ´Óë»·¾³×¨Ë¶ÕÐÉú
+1/1
visitor958
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2283 (½²Ê¦)
- ¹ó±ö: 0.05
- ½ð±Ò: 17310
- Ìû×Ó: 15735
- ÔÚÏß: 2926.6Сʱ
- ³æºÅ: 489254
3Â¥2011-03-09 16:14:09
2Â¥2011-03-09 16:09:59
4Â¥2011-03-09 16:35:48
chuzhufei
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SEPI: 5
- Ó¦Öú: 105 (¸ßÖÐÉú)
- ¹ó±ö: 0.001
- ½ð±Ò: 5829.3
- Ìû×Ó: 2608
- ÔÚÏß: 1857.6Сʱ
- ³æºÅ: 706214
5Â¥2011-03-09 16:37:07














»Ø¸´´ËÂ¥